GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **101 - 125** of **4050** in total

« First

‹ Prev

1

2

3

4

5

6

7

8

9

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID ▼	Arbitrary Fluorescence Units (AFU)
IgG	Patient 2	24	mild	G96881BQ	29
IgM	Patient 2	15	mild	G96881BQ	39
IgG	Patient 1	6	moderate	G96881BQ	26
IgM	Patient 1	6	moderate	G96881BQ	27
IgA	Patient 2	3	mild	G96881BQ	272
IgG	Patient 2	3	mild	G96881BQ	26
IgM	Patient 2	24	mild	G96881BQ	51
IgM	Patient 2	3	mild	G96881BQ	45
IgA	Patient 3	-180	mild	G96881BQ	277
IgA	Patient 3	11	mild	G96881BQ	389
IgG	Patient 3	-180	mild	G96881BQ	65
IgM	Patient 3	-180	mild	G96881BQ	109
IgA	Patient 3	4	mild	G96881BQ	430
IgG	Patient 3	11	mild	G96881BQ	58
IgG	Patient 3	4	mild	G96881BQ	50
IgM	Patient 3	11	mild	G96881BQ	141
IgM	Patient 3	4	mild	G96881BQ	139
IgA	Patient 4	12	mild	G96881BQ	382
IgG	Patient 4	12	mild	G96881BQ	117
IgM	Patient 4	12	mild	G96881BQ	252
IgA	Patient 1	10	moderate	G96865DJ	381
IgA	Patient 1	22	moderate	G96865DJ	492
IgA	Patient 1	6	moderate	G96865DJ	399
IgG	Patient 1	10	moderate	G96865DJ	76
IgG	Patient 1	22	moderate	G96865DJ	109